7 million Americans. By delivering continuous potassium data, the technology enables clinicians to adjust treatments for chronic kidney disease and heart‑related complications more safely and precisely, filling a critical gap in current monitoring capabilities.
Funding
$7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
5OFounders
Product
Problem
Patients with chronic kidney disease and heart conditions are at risk of hyperkalemia, a high blood potassium condition affecting over 3.7 million Americans. Current clinical practice lacks an on‑demand, continuous potassium monitoring method, forcing reliance on intermittent lab tests that can miss rapid changes and delay treatment adjustments.
Solution
Proton Intelligence has created a wearable sensor that continuously measures blood potassium levels and delivers real‑time data to clinicians. The device uses an electrochemical detection system integrated into a comfortable, ambulatory form factor, enabling patients to obtain potassium readings at any time without visiting a lab. Measured values are transmitted securely to a cloud platform where clinicians can view trends, set alert thresholds, and make immediate therapeutic decisions. By providing on‑demand potassium information, the solution supports safer dosing of medications, more precise management of dialysis, and reduced risk of cardiac events associated with hyperkalemia.
Target Audience
Primary customers are nephrologists, cardiologists, dialysis clinics, and healthcare systems that manage patients with chronic kidney disease or heart failure at risk of hyperkalemia.
Features
- Wearable electrochemical sensor that continuously samples interstitial fluid for potassium concentration
- Real‑time data streaming to a HIPAA‑compliant cloud dashboard accessible by healthcare providers
- Configurable alert system that notifies clinicians and patients when potassium exceeds predefined safety limits
- Integrated analytics that display longitudinal trends and support dosage adjustment decisions
- Battery‑efficient design allowing multi‑day operation without frequent recharging